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Conclusions. PTHrP significantly enhanced the low-Ca11–PTHrP enhances the secretory response of PTH to a hypocal-
stimulated PTH secretion in vivo and in vitro. An autocrine/cemic stimulus in rat parathyroid glands.
paracrine role of PTHrP in the parathyroid glands is suggested.Background. The secretion of parathyroid hormone (PTH)
An autoregulatory effect of circulating PTH on the PTH secre-from the parathyroid glands might be regulated by autocrine/
tion from parathyroid glands seems unlikely. The “maximalparacrine factors, and a feedback regulatory mechanism of
PTH on the secretion of PTH has been suggested. Because of secretory capacity” of the parathyroid glands induced by hypo-
the existence of a common receptor between PTH and PTH- calcemia in vivo and in vitro is not the maximum, as PTH
related peptide (PTHrP), the aim of the present study was to secretion can be increased even further, by several-fold.
examine the possible effects of PTHrP 1-40 and 1-86 on PTH
secretion in rats.
Methods. In vivo, the effect of PTHrP on Ca11-regulated
Parathyroid glands are not controlled by a superiorPTH secretion was examined by the induction of hypocalcemia
and hypercalcemia by an infusion of EGTA and Ca11, with “hypothalamic-pituitary” axis, as has been observed in
and without PTHrP. The eventual effects of PTHrP on the other endocrine glands. The parathyroid glands are there-
peripheral metabolism of PTH were examined by infusion of fore likely to use autocrine/paracrine regulatory mecha-
human PTH (hPTH) with and without PTHrP. hPTH was
nisms. Parathyroid hormone (PTH), chromogranin A,measured by an intact hPTH assay not cross reacting with rat
chromogranin A-related peptides, and endothelin-1 havePTH or PTHrP. To examine whether near physiological levels
of circulating PTH have an autoregulatory effect in vivo on all been suggested as factors that might influence PTH
PTH secretion from the parathyroid gland, an acute reduction secretion via an autocrine/paracrine mechanism [1–4].
of the circulating PTH was induced by an acute unilateral The primary focus of the present investigation was toparathyroidectomy (UPTX). PTH secretion from the re-
examine whether PTH might have a feedback regulatorymaining parathyroid gland was followed in response to EGTA-
effect on its own secretion from the parathyroid glands,induced hypocalcemia. In vitro investigations on the effect of
PTHrP 1-40 on PTH secretion from whole rat parathyroid as such an autoinhibitory mechanism previously has been
glands incubated in media containing a calcium concentration proposed [1]. A direct inhibitory effect of PTH 1-34 on
of 0.6 or 1.35 mmol/L were performed to confirm whether the
the PTH secretion of primary cultured cells from bovineeffect of PTHrP was directly on the gland. The rat PTH assay
parathyroid glands was shown in 1991 by Fugimi et alwas examined for cross reaction with PTHrP.
Results. In vivo, the same rate of decrease of plasma Ca11 [1]. In that study, it was found that PTH 1-34 in short-
was induced in the experimental groups. The maximal response time incubation (20 minutes) studies, at concentrations
of PTH to hypocalcemia (218 6 16 pg/mL, N 5 6) was signifi- as low as 10212 mmol/L, did inhibit the low-calcium–cantly enhanced by PTHrP 1-40 (525 6 79 pg/mL, N 5 6) and
stimulated PTH release. The authors suggested that anby PTHrP 1-86 (465 6 29 pg/mL, N 5 6, P , 0.001). No effect
amino-terminal PTH fragment(s) in the circulation mightof PTHrP on PTH secretion was found during normocalcemia
or hypercalcemia. UPTX resulted in a 50% reduction of PTH act in vivo as a physiological inhibitor(s) of the PTH
secretion, and no compensatory increase of PTH was observed. secretion and thereby exert a negative feedback mecha-
PTHrP had no effect on the metabolism of PTH. In vitro, low-
nism on the regulation of PTH secretion. A major diffi-Ca11–induced PTH secretion was significantly augmented by
culty in investigating the role of different PTH fragments300% (P , 0.01) when the medium contained PTHrP 1-40.
PTHrP did not cross react with the PTH assay. on PTH secretion is the cross reactivity in the assays.
Thus, in the present investigation, we decided to use
N-terminal fragments of PTH-related peptide (PTHrP)Key words: calcium-PTH curve, autocrine-paracrine factor, hypercal-
cemia, uremia, secondary hyperparathyroidism. instead of PTH fragments in order to activate the com-
mon PTH/PTHrP receptor, as the N-terminal PTHrPReceived for publication April 21, 1999
fragments are equipotent to N-terminal PTH fragmentsand in revised form January 12, 2000
Accepted for publication February 18, 2000 as ligands for the receptor [5, 6]. The immunoreactivity
of the two hormones are different, however, and PTHrPÓ 2000 by the International Society of Nephrology
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will not be detected by the PTH immunoassay. As such, ally. For the in vitro studies, parathyroid glands from
Wistar rats were used.the amount of PTHrP added will not be measured as a
PTH response.
PeptidesOur results were surprising as no inhibitory effect of
Parathyroid hormone-related peptide 1-40, PTHrP 1-86,PTHrP on PTH secretion was shown, but, on the con-
and human PTH (hPTH) 1-84 were obtained from Saxontrary, they suggested the possibility of an autocrine/para-
Biochemicals, GMBH (Hannover, Germany).crine stimulatory function of PTHrP in the parathyroid
The in vivo bovine PTH inhibitor, (Tyr34)bPTH-(7-glands.
34)amide [20], was obtained from Peninsula Labora-Parathyroid hormone-related peptide was originally
tories, Inc. (Belmont, CA, USA). For the in vivo andidentified as a malignant tumor-derived humoral factor
the in vitro studies, PTHrP fragments were first dissolvedcausing hypercalcemia [7, 8]. However, the PTHrP gene
in deionized water to a concentration of 1 mg/mL andis expressed in almost every tissue and every organ dur-
then further dissolved in saline to the concentrationing the fetal development, as well as in the adult organism
needed. The concentrations of hormones and cytokines[5, 9]. Disruption of the PTHrP gene is lethal [10]. Today,
in an autocrine/paracrine milieu are not known, but aremany researchers have directed their focus on the normal
probably several-fold higher than the concentrations inphysiological functions of PTHrP [11–17]. Through alter-
the circulation. In the present study, we therefore usednative splicing, the PTHrP gene yields an array of
dosages of PTHrP similar to those used in other investi-mRNA species. Translation of the PTHrP mRNA spe-
gations on autocrine/paracrine actions [14, 21].cies gives rise to three related initial translation products
with distinct COOH terminals. The part of homology
with PTH is only from amino acid 1 through 13. Amino EXPERIMENTAL PROTOCOLS
acids 14 to 34 share no homology with PTH, but are Effect of PTHrP on low-Ca11–stimulated PTH
important for binding to the PTH/PTHrP receptor. Thus, secretion in vivo
the N-terminal fragments 1-34 of PTH and PTHrP have
Hypocalcemia was induced by an infusion of 30 mmol/La similar affinity for the common receptor. Post-transla-
ethylene-bis(oxyethylene-nitrilo) tetraacetic acid (EGTA;tional processing results in several mature secretory frag-
Sigma, St. Louis, MO, USA), 3 mL/hour through a cathe-ments of PTHrP: one mature fragment is PTHrP 1-36;
ter inserted in the femoral vein. Samples for determina-other mature midregion fragments of PTHrP beginning
tion of plasma PTH (p-PTH) and plasma Ca11 (p-Ca11)at amino acid 38 have been identified, and PTHrP 107-
were taken at 0, 5, 10, 20, 30, 40, and 50 minutes from a139 has been suggested to be a mature secretory form
corresponding catheter in the femoral artery. The sample
of PTHrP. Each fragment may have its own specific
volume of 0.8 mL was replaced by 0.8 mL of saline,
receptor and unique physiologic effects [5, 6]. resulting in the same weight of the rats before and after
In the present investigation in rats, the effect of exoge- the experiments.
nous PTHrP 1-40 and 1-86 on the calcium-regulated PTH Two different intravenous doses (in mg) were used of
secretion in vivo as well as in vitro in rat parathyroid the two different PTHrP fragments in order to obtain
glands was examined. The understanding of the regula- equimolar concentrations of the peptides. The following
tion of PTH secretion is of significant importance for three experimental groups, using the two different
the nephrologist, as uremia is associated with the devel- PTHrP fragments or vehicle, were performed:
opment of secondary hyperparathyroidism. The Ca11/ Group 1. A group of rats received a bolus of 1 mL
PTH curves are often used in the evaluation of uremic of 100 mg/mL of PTHrP 1-40 at time 0 (N 5 6).
patients and are often difficult to interpret [18, 19]. Group 2. A group of rats received a bolus of 1 mL
of 200 mg/mL of PTHrP 1-86 at time 0 (N 5 6).
Group 3. A group of rats received 1 mL of vehicleMETHODS
only (N 5 6).
Animals
Effect of PTHrP on high-Ca11–suppressed PTHInbred male DA rats, weighing 250 g, were used for
secretion in vivothe in vivo studies. The experimental studies on the rats
were performed in accordance with the National Insti- Hypercalcemia was induced by continuous infusion of
tutes of Health Guide for Care and Use of Laboratory 25 mmol/L Ca11 (Calcium-Sandoz), 3 mL/hour, for 40
Animals and were approved by our institution. The rats minutes, through a catheter inserted in the femoral vein.
were kept on a standard diet containing 0.9% Ca, 0.7% Samples for determination of p-Ca11 and p-PTH were
phosphorus, and 1000 IU vitamin D/kg. The experimen- obtained at 0 and after 40 minutes of calcium infusion.
tal procedures were performed in rats under anesthesia The secretory response of PTH to the two PTHrP frag-
ments was the same in the experiments presented pre-with Mebumal (Pentobarbithal) 50 mg/kg intraperitone-
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viously in this article. Therefore, only PTHrP 1-40 was the PTH secretion from the remaining parathyroid gland
was followed in response to hypocalcemia.used in the remaining part of the present investigations.
Unilateral parathyroidectomy was performed as a se-Group 4. A group of rats received a bolus of 1 mL
lective removal of one of the two parathyroid glands byof 100 mg/mL of PTHrP 1-40 at time 0 (N 5 3).
a microsurgical technique, while the second gland wasGroup 5. A group of rats received 1 mL of vehicle
left in situ. This technique of parathyroidectomy wasonly (N 5 6).
previously evaluated in our lab [22].
Effect of PTHrP on PTH secretion during a The group of rats that had UPTX performed at 30
continuous decrease in p-Ca11 from hypercalcemia to minutes after starting the EGTA infusion was used as a
normocalcemia and hypocalcemia in vivo control group for the effect of surgery on the initial
response to hypocalcemia. In this group of rats, the para-Hypercalcemia was first induced by continuous infu-
thyroid glands were exposed before the start of thesion of 25 mmol/L Ca11 (Calcium-Sandoz), 3 mL/hour,
EGTA infusion, and then one of the glands was dissectedfor 40 minutes, through a catheter inserted in the femoral
by microsurgery after 30 minutes of EGTA infusion. Thevein. Then the Ca11 infusion was discontinued, and a
UPTX procedure took approximately one minute.sample for determination of p-Ca11 and p-PTH was
Group 10. One group of rats was UPTX, just beforeobtained. PTHrP 1-40, 100 mg or vehicle, was injected
start of the induction of hypocalcemia by a continuousas a bolus to hypercalcemic rats, and then the EGTA
EGTA infusion (N 5 8).infusion was initiated immediately. As such, p-Ca11 was
Group 11. Another group of rats received UPTX dur-gradually reduced from hypercalcemia to hypocalcemia
ing the EGTA infusion, at the time when the “maximalby a continuous EGTA infusion, 30 mmol/L, at a rate
secretory response” of PTH to stimulation with hypocal-of 3 mL/hour, for 60 minutes. Plasma PTH and p-Ca11
cemia already had been achieved. In this model, anwere measured after 5 minutes and then at every 10
EGTA infusion was initiated in the intact rat and contin-minutes.
ued during and after the UPTX. After 30 minutes ofGroup 6. A group of rats received PTHrP 1-40, 100
infusion, a blood sample for determination of p-Ca11
mg (N 5 6).
and p-PTH was obtained, and UPTX was performed.Group 7. A group of rats received vehicle only (N 5 6).
Then, p-PTH and p-Ca11 levels were followed for an-
other 20 minutes (N 5 8).Effect of PTHrP on the peripheral disappearance of
Group 12. A control group of rats with intact parathy-synthetic hPTH 1-84, injected into rats
roid glands was tested (N 5 6).
To exclude a possible influence of PTHrP administra- In all three groups (Groups 10 to 12), 30 mmol/L
tion on the peripheral metabolism of PTH, 3.5 ng of EGTA was infused at a rate of 3 mL/hour through a
hPTH 1-84 were injected into rats, together with PTHrP catheter inserted in the femoral vein. Samples for deter-
1-40, 100 mg, or vehicle. Samples for the determination mination of p-PTH and p-Ca11 were obtained at 0, 5,
of hPTH 1-84 were obtained at every 4 minutes for 28 10, 20, 30, 40, and 50 minutes from a corresponding
minutes. catheter in the femoral artery.
Human PTH 1-84 was measured by an intact hPTH
(IRMA) assay (Nichols Institute, San Juan Capistrano, Effect of PTHrP on normal- and low-Ca11–stimulated
CA, USA), which does not cross-react with rat PTH or PTH secretion in vitro from whole rat
with PTHrP, as tested in our lab. parathyroid glands
Group 8. A group of rats received 3.5 ng of hPTH A detailed description and evaluation of this in vitro
1-84, together with PTHrP 1-40, 100 mg (N 5 8). model has been published previously [23]. In brief, rat
Group 9. A group of rats received 3.5 ng of hPTH parathyroid glands were removed by microsurgery. Ten
1-84, together with vehicle (N 5 8). whole glands were incubated in 2 mL of a medium con-
taining 25 mmol/L HEPES, 5.6 mmol/L KCl, 125 mmol/L
Effect of an acute 50% reduction of the parathyroid NaCl, 1.25 mmol/L CaCl2, 0.5 mmol/L MgCl2, 1 mmol/Lmass on the plasma PTH levels during induction Na2HPO4, 12 mmol/L glucose, 0.1% bovine serum albu-of hypocalcemia min (BSA), insulin 10 IU/L, streptomycin 100 mg/mL,
These experiments were performed in order to exam- penicillin 100 IU/mL, l-glutamine 4 mmol/L, pyruvate
ine whether near physiologic levels of circulating PTH, 1 mmol/L, at a pH of 7.4, 378C, and 5% CO2. The glands
on a minute-to-minute basis, have an autoregulatory ef- were transferred into fresh medium every 60 minutes.
fect in vivo on PTH secretion from the parathyroid gland. After four hours of preincubation at Ca11 of 1.25
An acute reduction of the circulating PTH levels was mmol/L, a stable PTH secretion was obtained.
obtained by a 50% reduction of the glandular mass by Experiment 13. The first series of experiments was
then conducted at the following conditions: a 1.25an acute unilateral parathyroidectomy (UPTX). Then,
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mmol/L Ca11 medium for one hour, glands transferred
to a 0.6 mmol/L Ca11 medium for one hour, and then
transferred to a 0.6 mmol/L Ca11 medium with or with-
out 1026 mol/L PTHrP 1-40 for one hour, and then incu-
bated in a new 0.6 mmol/L Ca11 medium with or without
1026 mol/L PTHrP 1-40 for one more hour (N 5 6).
Experiment 14. In a second series of experiments, the
conditions were a 1.25 mmol/L Ca11 medium for one
hour, and that transferred to a 1.35 mmol/L Ca11 me-
dium for one hour, and again transferred to a 1.35-
mmol/L Ca11 medium with or without 1026 mol/L
PTHrP 1-40 for one hour, and then incubated again with
PTHrP for another hour (N 5 5).
The results are expressed as PTH secretion, accumu-
lated from 10 glands, incubated in 2 mL of medium for
one hour.
Cross-reactivity of PTHrP in the rat PTH assay
Parathyroid hormone-related peptide 1-40, PTHrP
1-86, and (Tyr34)bPTH-(7-34)amide at concentrations Fig. 1. Detection of rat parathyroid hormone (PTH) 1-84 (j), parathy-
roid hormone-related peptide (PTHrP) 1-40 (.), PTHrP 1-86 (.), andfrom 1025 to 10213 mol/L were examined for cross-reac-
the bovine PTH inhibitor [(Tyr34)bPTH-(7-34)amide] (h) in the rattivity in the rat PTH assay. PTH (IRMA) assay. The PTHrP fragments were not detected in the assay.
Plasma measurements
Plasma PTH was measured by a rat PTH (IRMA) significantly (P , 0.03) to a lower level, despite a continu-
assay from Nichols Institute. The intra-assay variation ous fall in Ca11. The PTH levels remained, however,
in our laboratory was 4%, and the interassay variation significantly higher (P , 0.03) than those observed be-
was 35% for a PTH level of 7 pg/mL, 5% for PTH of fore the EGTA infusion.
40 pg/mL, and 5% for PTH of 260 pg/mL. No cross- Administration of PTHrP 1-40 as well as of PTHrP
reactivity with C-terminal PTH fragments was found in 1-86 both significantly enhanced (P , 0.001), and to the
our laboratory. Plasma Ca11 at actual pH was measured same extent, the low-calcium–stimulated PTH secretion
by a calcium-selective electrode (Radiometer, Copenha- in the rats, as shown in Figure 3A. The p-Ca11 levels
gen, Denmark). were reduced by exactly the same rate in the three exper-
imental groups (Figure 3B).
Statistics As the effects of the two N-terminal PTHrP fragments
The results are expressed as mean 6 SEM. The Mann– were similar, only PTHrP 1-40 was used in the remaining
Whitney test was used for comparison between groups. portion of the investigations.
P , 0.05 was considered significant.
Effect of PTHrP on high-Ca11–suppressed PTH
secretion in vivo
RESULTS
Basal p-Ca11 of 1.30 6 0.01 was raised to a level of
Cross-reactivity of PTHrP in the rat PTH assay 1.69 6 0.01 mmol/L by a 40-minute continuous infusion
Parathyroid hormone-related peptide 1-40 and 1-86 of calcium. Despite the administration of PTHrP 1-40,
did not cross react with the rat PTH assay. A significant a complete suppression of PTH levels from 22 6 2 to
cross-reactivity, however, was found for an in vivo PTH 6 6 1 pg/mL was obtained, similar to the values of a
inhibitor (Tyr34)bPTH-(7-34)amide in the rat PTH as- non–PTHrP-treated control group (p-Ca11 from 1.29 6
say. Therefore, this peptide was not used for further 0.01 to 1.69 6 0.04 mmol/L and p-PTH from 34 6 8 to
experiments. The results are shown in Figure 1. 5 6 0.3 pg/mL).
Effect of PTHrP on low-Ca11–stimulated Effect of PTHrP on PTH secretion during a
PTH secretion in vivo continuous decrease in p-Ca11 from hypercalcemia to
normocalcemia and hypocalcemia in vivoThe secretory response of PTH to an acute induction
of hypocalcemia is shown in Figure 2. The transient pat- A significant (P , 0.001) and severe hypercalcemia
tern of the initial increase in PTH levels in response to was induced in all rats, and a significant suppression of
the reduction in plasma Ca11 is shown. An initial rapid the PTH secretion was obtained (Fig. 4). When PTHrP
or vehicle was injected during hypercalcemia, the PTHincrease in PTH levels was observed, which then declined
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Fig. 2. The Ca11/PTH relationship during an acute induction of hypo-
calcemia by an EGTA infusion in the rat. The transient pattern of the
initial increase of PTH secretion in response to the reduction of plasma
Ca11 is shown (N 5 6, mean 6 SEM).
levels remained suppressed in both experimental groups.
These results confirmed that PTHrP is not a stimulus
for PTH secretion in hypercalcemia. Furthermore, it was
shown that PTHrP given in vivo was not cross-reacting
with the rat PTH assay. The p-Ca11 levels were then
reduced gradually by an EGTA infusion.
In the normocalcemic range, the PTH levels were not
significantly different between the two experimental Fig. 3. Effect of PTHrP on the secretory response of PTH to an acute
induction of hypocalcemia (A) induced by an EGTA infusion. The rategroups in this model. In PTHrP-treated group, p-PTH
of reduction of p-Ca11 was similar in all groups of rats (B). A boluswas 149 6 56 pg/mL at a mean p-Ca11 of 1.25 mmol/L, of PTHrP 1-40 (m), PTHrP 1-86 (.), or vehicle (j) was injected at
while in the vehicle-treated group, p-PTH was 117 6 51 time 0. PTHrP significantly enhanced (P , 0.001) the low-Ca11–
stimulated PTH secretion in vivo (N 5 6 in each group, mean 6 SEM).pg/mL at a mean p-Ca11 of 1.22 mmol/L.
In hypocalcemia, p-PTH levels were, however, signifi-
cantly enhanced in the PTHrP-treated group, as com-
pared with the vehicle-treated group (P , 0.001). The
results of the Ca11/PTH levels are shown in Figure 4. Effect of PTHrP on the peripheral disappearance
When EGTA was infused into hypercalcemic rats, the
of synthetic hPTH 1-84 injected into ratsdevelopment of hypocalcemia was significantly faster in
The rate of disappearance of hPTH 1-84 was not in-the PTHrP-treated group (P , 0.01) than in the control
fluenced by PTHrP in the doses used in the experimentsgroup, and this might have contributed to the extent of
enhanced PTH secretion in this group. (Fig. 5).
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Effect of an acute 50% reduction of the parathyroid
mass on the plasma PTH levels during induction
of hypocalcemia
Unilateral parathyroidectomy, which was performed
just before initiation of the EGTA infusion or during
the EGTA infusion, but after maximal PTH secretion
had been induced, resulted in a significant (P , 0.05)
reduction of the PTH secretion by 50% in both groups
10 and 11. Then plasma-PTH remained stable at this
lower level (Figure 6A).
Thus, a decrease in the circulating levels of PTH and
thereby a decrease of a theoretical inhibitory effect of
PTH on its own secretion did not result in an acute up-
regulation of the PTH secretion from the single parathy-
roid gland, which was left in situ. The p-Ca11 levels were
reduced by exactly the same rate in all experimental
groups (Fig. 6B).
Effect of PTHrP on normal- and low-Ca11–stimulated
PTH secretion in vitro from whole ratFig. 4. Ca11/PTH relationship during hyper-, normo-, and hypocal-
parathyroid glandscemia in rats receiving PTHrP 1-40 (j) or vehicle (h). A bolus of
PTHrP or vehicle was given to the rats after hypercalcemia was induced Parathyroid hormone secretion was significantly stim-by a Ca11 infusion. Then, Ca11 was gradually reduced by an EGTA
ulated (P , 0.002) when whole parathyroid glands wereinfusion. Arrow on the absissa depicts the direction of change in p-Ca11.
During hypercalcemia and normocalcemia, PTH levels were not influ- transferred from a medium with a Ca11 concentration
enced by PTHrP, while in hypocalcemia, PTHrP significantly enhanced of 1.25 mmol/L to a medium with a low Ca11 concen-the PTH levels (P , 0.001, N 5 6 in each group, mean 6 SEM).
tration of 0.6 mmol/L. PTHrP 1-40 further significantly
enhanced the low-Ca11–stimulated PTH secretion
(P , 0.01; Fig. 7). When the parathyroid glands were
transferred from a Ca11 concentration of 1.25 mmol/L
to a Ca11 concentration of 1.35 mmol/L, a slight but
significant decrease of the PTH secretion was induced
(P , 0.01). PTHrP 1-40 significantly enhanced
(P , 0.008) the PTH secretion in the normal calcium
medium, but less as compared with the low-calcium me-
dium (Fig. 7).
DISCUSSION
In the present investigation, it was clearly shown that
the N-terminal fragments of PTHrP, PTHrP 1-40, and
PTHrP 1-86 significantly enhanced the low-calcium–
stimulated PTH secretion in vivo in the rat. This effect
was not caused by any alteration in the rate of decrease
of p-Ca11 or by any effect of PTHrP on the peripheral
metabolism of PTH. This direct effect of PTHrP on the
parathyroid glands was confirmed by the enhancement
of the low-calcium–stimulated PTH secretion in an in
vitro system. PTH secretion in vivo was, however, only
affected by PTHrP during hypocalcemia and not during
hypercalcemia. In normocalcemia, no significant effect
of PTHrP was found on PTH secretion in vivo, while aFig. 5. Effect of PTHrP on the peripheral metabolism of PTH. Syn-
thetic human PTH 1-84 (hPTH; 3.5 ng) was injected together with 100 stimulatory effect was seen in vitro at a calcium concen-
mg of PTHrP 1-40 (r) or vehicle (m) into the rat. Plasma levels of tration of 1.35 mmol/L in the medium, a calcium concen-
hPTH were measured by an intact hPTH IRMA assay, which does not
tration that is equivalent to the p-Ca11 concentrationcross react with rat PTH. The disappearance of hPTH 1-84 was not
affected by PTHrP (N 5 8 in each group, mean 6 SEM). that we find in normal rats on a normal diet. This discrep-
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Fig. 7. Effect of PTHrP 1-40 on normal- and low-Ca11–stimulated
PTH secretion in vitro from whole rat parathyroid glands. PTH secre-
tion was significantly stimulated (P , 0.002) by a low Ca11 concentra-
tion of 0.6 mmol/L. PTHrP further significantly enhanced the low-
Ca11–stimulated PTH secretion (P , 0.01, N 5 6). Furthermore, PTHrP
significantly enhanced (P , 0.008) the PTH secretion in the 1.35 mmol/L
calcium-containing medium, but less as compared with the low-calcium
medium (N 5 5, mean 6 SEM).
been examined in freshly harvested intact parathyroid
glands [24]. The direction of calcium changes in the in
vivo model, when p-Ca11 was gradually decreased from
hypercalcemic to hypocalcemic levels, might also be im-
portant [18]. However, it was not possible to create an
in vivo model of stable normocalcemia in PTHrP-treated
rats. As in intact rats, an immediate mild decrease of p-
Ca11 was the consequence of PTHrP given intrave-
nously (data not shown). This is in line with previous
results on rats and dogs showing that the initial response
to an injection of PTH was, in fact, hypocalcemia before
hypercalcemia developed [25, 26].
It is well established that PTHrP is expressed in theFig. 6. Effect of an acute 50% reduction of the parathyroid mass on the
plasma PTH levels (A) during EGTA-induced hypocalcemia. Unilateral parathyroid glands from fetal to adult life in different
parathyroidectomy (UPTX) was performed just before (j) or after 30 species [5], but the physiological function of this hor-
minutes of EGTA infusion (h). Control rats were not UPTX (,). The
mone remains unclear. The PTHrP secretion from thearrows depict the time of UPTX, which reduced the glandular mass
and the plasma PTH levels by 50%. A similar rate of reduction of parathyroid glands of the fetus has a critical role in main-
p-Ca11 was obtained in all groups of rats (B). (N 5 6 in each group,
taining the fetal blood calcium and in stimulating themean 6 SEM).
active transport of calcium across the placenta [27–31].
However, the role of PTHrP as the major calcium-regu-
lating hormone during gestation in rats has been ques-ancy could theoretically be due to altered sensitivity for
tioned, as a strong expression of the PTH gene andcalcium of the parathyroid cells in the in vitro model,
no transcription of the PTHrP gene were detected byalthough a rapid down-regulation of the calcium-sensing
hybridization histiochemistry in parathyroid glands of areceptor at present has only been shown to occur in vitro
in cultured and dispersed parathyroid cells and has not 17.5-day-old embryos, similar to the findings in adult
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rats [32]. Thus, the existence of a fundamental species has been proposed from experiments on the supraoptic
nucleus of the rat [40]. Theoretically, activation of adifference in the fetal regulation of calcium has been
proposed, which also might be relevant to explain the unique PTHrP receptor by PTHrP 1-40 or PTHrP 1-86
might explain that we found a strong stimulatory effectpresent results in adult rats. However, using the sensitive
technique of reverse transcription-polymerase chain re- of PTHrP, while Fugimi et al found an inhibitory effect of
PTH on PTH secretion [1]. In the present investigation,action, a weak expression of PTHrP cDNA has been
detected in adult rat thyroid/parathyroid tissue [32]. Fur- acute UPTX was performed, and the parathyroid mass
was reduced by 50%. The circulating PTH levels werethermore, in two separate studies, it was found that the
immortalized rat parathyroid cell line produces PTHrP reduced by 50% as well, indicating that the parathyroids
do not have an immediate compensatory up-regulatoryand not PTH, and that PTHrP secretion could be inhib-
ited by an elevation of the calcium concentration in the effect on PTH secretion. Thus, the present results are
contrasting to the assumption that the circulating physio-medium [33, 34]. Thus, evidence of the presence of
PTHrP in the rat parathyroid gland is still emerging. logical levels of PTH should have a feedback regulatory
effect on the rate of PTH secretion.Parathyroid hormone-related peptide mRNA and
protein are expressed in human parathyroid adenomas In the present investigation, we used PTHrP 1-40 and
PTHrP 1-86 in order to include a possible role of aand hyperplasia [9, 35, 36]. It has been postulated that
PTHrP has growth/differentiation effects in the parathy- midregion PTHrP fragment. However, no significant dif-
ference in the stimulatory effect on PTH secretion duringroid glands. Matsushita et al studied the intracytoplasmic
distribution and the secretion of PTH and PTHrP in hypocalcemia was found between the two peptides used.
This suggests that the stimulatory effect shown is anparathyroid adenomas [37]. PTH and PTHrP were colo-
calized in the same secretory granules and secreted si- effect of the N-terminal PTHrP. The rat IRMA PTH
assay, which was used in the present investigation, usesmultaneously. Recently, Matsushita et al studied para-
thyroid hyperplasia secondary to chronic renal failure in two antibodies targeting the N-terminal part of the PTH
molecule. The assay was carefully tested for cross reactiv-humans [38]. In a total of 42 glands, 64% were positive
for PTHrP staining by immunohistochemistry, with no ity with C-terminal PTH fragments, including a long
7-84 PTH fragment and a midmolecule 44-68 fragment,difference observed between the diffuse and the nodular
types of hyperplasia. A similar distribution of PTHrP and no cross-reactivity was found. It is therefore not
likely that the PTH response, which was measured, ismRNA was found. The proliferative activity of the para-
thyroid cells, as evaluated by the expression of the prolif- due to a reduced clearance of midregion or C-terminal
fragments. Recently, it has been reported [41, 42], how-erating cell nuclear antigen, correlated negatively with
the expression of PTHrP. Therefore, an inhibitory effect ever, that in renal failure the presence of a significant
cross reactivity of the human intact PTH assay with non-of PTHrP on the parathyroid cell proliferation was pos-
tulated [38]. In the same study, the investigators found [1-84] PTH material may take place. Thus, the possibility
exists that PTHrP treatment may result in the release ofthat most parathyroid cells were immunochemically posi-
tive for the presence of the PTH/PTHrP receptor. This non-[1-84] PTH material, which is detected by the rat
PTH assay.further supports the possibility of an autocrine/paracrine
function of PTHrP in the parathyroids. Previous studies have shown that calcium affects the
metabolism of PTH, and it cannot be excluded that hypo-A direct inhibitory effect of PTH 1-34 on the PTH
secretion of primary cultured cells from bovine parathy- calcemia might have had an effect on the metabolism of
PTH. In our laboratory we have previously studied suchroid glands was shown by Fugimi et al [1]. The present
results, which demonstrate a strong stimulatory effect of an effect of different calcium concentrations on the me-
tabolism of PTH in the isolated perfused liver and kidneyPTHrP 1-40 and of PTHrP 1-86 on PTH secretion, might
be in contrast to the results of Fugimi et al, but only on [43]. It was found that low Ca11 resulted in a lower
hepatic clearance of intact PTH than at high Ca11. Thus,the assumption that the effects of N-terminal PTH and
of PTHrP fragments are exerted via the common PTH/ it is possible that hypocalcemia might have contributed
slightly to the increase in PTH levels. However, it isPTHrP receptor [1]. The recent demonstration of a PTH/
PTHrP receptor in the parathyroids supports such a important to stress that the present in vitro studies
showed the same stimulatory effect of PTHrP on PTHmechanism [38]. However, we must consider the possible
existence of other receptors that respond only to PTH secretion, excluding that the in vivo results can be simply
due to an effect of a disturbed metabolism.or only to a PTHrP(s). As such, a PTH-2 receptor, which
is activated exclusively by PTH, but not by PTHrP, has We therefore conclude that in the concentrations used,
PTHrP is a secretogogue for PTH during hypocalcemia.been cloned. However, this receptor has not been detect-
able in the rat parathyroids by in situ hybridization histo- Such a secretogogal role of PTHrP on PTH secretion is
in line with previous results showing a similar enhancingchemistry [39]. A novel type of PTHrP receptor re-
sponding only to PTHrP 1-34, but not to PTH 1-34, effect of dopamine and norepinephrine on the already
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stimulated PTH secretion at hypocalcemia, but with no and in vitro. The mechanism is as yet unknown, but an
enhancing effect when PTH secretion was suppressed autocrine/paracrine role of PTHrP in the parathyroid
by hypercalcemia [44]. glands is suggested. An autoregulatory effect of circulat-
Based on the presence of PTHrP in the parathyroid ing PTH on the PTH secretion from the parathyroids
glands of several species and on the results of the present seems unlikely. What has been considered as the “maxi-
investigation, a paracrine/autocrine role of PTHrP is pro- mal secretory capacity” of the parathyroid glands in vivo
posed. However, the physiologic role of PTHrP in the and in vitro is in fact not the maximum, as the PTH
parathyroid glands remains to be established. secretion significantly can be increased even further by
It has previously been demonstrated that the maximal several-fold.
response of PTH secretion is dependent on the rate of The present results may have a critical influence on
decline of p-Ca11 [45]. In the present study, the rate of the frequent use of the Ca11/PTH curves in uremic pa-
p-Ca11 decline was well controlled when EGTA was tients and on the interpretation of results demonstrating
infused into normocalcemic rats, and was the same in different maxima in different clinical and experimental
the group of rats with PTHrP infused and in the control conditions.
group. Despite the same rate of Ca11 decline, PTHrP-
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